Tetraphase Pharma Inc (TTPH:NASDAQ) Investor Relations Material

Overview

Tetraphase is a clinical-stage biopharmaceutical company that specializes in creating antibiotics for severe and life-threatening bacterial infections. Using its innovative chemistry technology, the company aims to combat multidrug-resistant (MDR) bacteria, which have been identified as crucial public health risks by the CDC. With a focus on addressing urgent medical needs, Tetraphase is pioneering new solutions to combat antibiotic resistance and improve patient outcomes.

Frequently Asked Questions

What is Tetraphase Pharma Inc's ticker?

Tetraphase Pharma Inc's ticker is TTPH

What exchange is Tetraphase Pharma Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Tetraphase Pharma Inc's headquarters?

They are based in Watertown, Massachusetts

How many employees does Tetraphase Pharma Inc have?

There are 51-200 employees working at Tetraphase Pharma Inc

What is Tetraphase Pharma Inc's website?

It is http://www.tphase.com

What type of sector is Tetraphase Pharma Inc?

Tetraphase Pharma Inc is in the Healthcare sector

What type of industry is Tetraphase Pharma Inc?

Tetraphase Pharma Inc is in the Drugs - Generic industry

Who are Tetraphase Pharma Inc's peers and competitors?

The following five companies are Tetraphase Pharma Inc's industry peers:

- Catalyst Pharmaceuticals

- Sophiris Bio Inc.

- Catalent

- Fibrocell Science Inc

- Pacira BioSciences Inc